Integrating the discovery pipeline for novel compounds targeting ion channels
- 3 August 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Chemical Biology
- Vol. 12 (4), 441-447
- https://doi.org/10.1016/j.cbpa.2008.07.012
Abstract
Many ion channels are attractive therapeutic targets for the treatment of neurological or cardiovascular diseases; there is a continuous need for selective channel antagonists and/or agonists. Recently, several technologies have been developed that make exploration of the enormous diversity of venom-derived peptidic toxins more feasible. Integration of exogenomics with synthetic methods such as diselenide or fluorous bridges, backbone spacers, and N-to-C cyclization provides an emerging technology that promises to accelerate discovery and development of natural products based compounds. These drug-discovery efforts are complemented by novel approaches to modulate the activities of ion channels and receptors. Taken together, these technologies will advance our knowledge and understanding of ion channels and will accelerate their expansion as targets for first-in-class therapeutics.Keywords
This publication has 49 references indexed in Scilit:
- A global assembly line for cyanobactinsNature Chemical Biology, 2008
- α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding ResiduesJournal of Molecular Biology, 2008
- ATDB: a uni-database platform for animal toxinsNucleic Acids Research, 2007
- Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogueBiochemical and Biophysical Research Communications, 2007
- Chemical Modification of Conotoxins to Improve Stability and ActivityACS Chemical Biology, 2007
- Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptorProceedings of the National Academy of Sciences of the United States of America, 2007
- Sea anemone venom as a source of insecticidal peptides acting on voltage-gated Na+ channelsToxicon, 2006
- Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Studies on deprotection of cysteine and selenocysteine side‐chain protecting groupsJournal of Peptide Science, 2006
- Solid‐Phase Synthesis and Biological Activity of a Thioether Analogue of Conotoxin G1ChemBioChem, 2003